NITROUS OXIDE CONSCIOUS SEDATION--ANXIOYSIS
NITROUS OXIDE CONSCIOUS SEDATION--ANXIOYSIS
批准号:
3425483
负责人:
RAYMOND MARK QUOCK
金额:
$2.22万
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-08-01 至 1992-01-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Nitrous oxide is widely used for production of conscious sedation in
clinical dentistry. This clinical application of low concentrations of
nitrous oxide specifically for reduction of anxiety is unique to dentistry.
Nitrous oxide also possesses prominent analgesic and weak anesthetic
properties that have been widely studied. However, its anxiolytic effect
has not been well investigate and the underlying mechanism(s) of action
remain(s) unknown. Recent research suggests that an apparent anxiolytic
effect of nitrous oxide is demonstrable in the mouse staircase test, a
relatively new anxiety paradigm. This application proposes pilot
experiments to determine the feasibility of future basic research into the
mechanism of anxiolytic effect of nitrous oxide. The goals of this
proposed research are to study 2 established and validated experimental
paradigms (the social interaction test and the defensive burying test in
rats): (1) a concentration-dependent anxiolytic effect of nitrous oxide and
comparison with chlordiazepoxide (an anxiolytic standard) and morphine (an
analgesic standard); and (2) sensitivity of the effects of these 3 drug
challenges (nitrous oxide, chlordiazepoxide and morphine) to interaction
with opioid and benzodiazepine receptor blockers. Carried to a successful
conclusion, this proposed research will make possible further and more
sophisticated investigations for characterization of the anxiolytic effect
of nitrous oxide and elucidation of its mechanism(s) of action. The long
term objective of this research is to continue a systematic analysis of the
pharmacological properties of nitrous oxide. The findings of such research
should advance our understanding of the pharmacology of nitrous oxide and
contribute to more efficacious or judicious clinical use of nitrous oxide
in dentistry and medicine.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Benzodiazepine receptor mediation of behavioral effects of nitrous oxide in mice.
苯二氮卓受体介导一氧化二氮对小鼠行为的影响。
DOI:
10.1007/bf02245153
发表时间:
1992
期刊:
Psychopharmacology
影响因子:
3.4
作者:
[Quock,RM, Emmanouil,DE, Vaughn,LK, Pruhs,RJ]
通讯作者:
Pruhs,RJ
Nitrous oxide induces an anxiolytic-like effect in the conditioned defensive burying paradigm, which can be reversed with a benzodiazepine receptor blocker.
一氧化二氮在条件性防御性掩埋范式中会产生类似抗焦虑的作用,这种作用可以用苯二氮卓受体阻滞剂逆转。
DOI:
10.1007/bf02245699
发表时间:
1993
期刊:
Psychopharmacology
影响因子:
3.4
作者:
[Czech,DA, Quock,RM]
通讯作者:
Quock,RM
Benzodiazepine receptor-mediated behavioral effects of nitrous oxide in the rat social interaction test.
大鼠社交互动测试中一氧化二氮受体介导的苯二氮卓受体介导的行为效应。
DOI:
10.1016/0091-3057(93)90335-q
发表时间:
1993
期刊:
Pharmacology, biochemistry, and behavior
影响因子:
--
作者:
[Quock,RM, Wetzel,PJ, Maillefer,RH, Hodges,BL, Curtis,BA, Czech,DA]
通讯作者:
Czech,DA
Hyperbaric Oxygen: A Novel Approach to Treatment of Chronic Pain
-
批准号:8430875
-
项目类别:
-
资助金额:$22.89万
-
财政年份:2012
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
Hyperbaric Oxygen: A Novel Approach to Treatment of Chronic Pain
-
批准号:8543641
-
项目类别:
-
资助金额:$17.19万
-
财政年份:2012
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
NO mechanisms in N2O antinociception in inbred mice
-
批准号:7191775
-
项目类别:
-
资助金额:$21.26万
-
财政年份:2007
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
SIGNALING PATHWAY FOR BENZODIAZEPINE INDUCED BEHAVIORS
-
批准号:2013564
-
项目类别:
-
资助金额:$9.25万
-
财政年份:1997
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
GENETIC CONTROL OF RESPONSIVENESS TO N20 ANTIOCICEPTION
-
批准号:6017457
-
项目类别:
-
资助金额:$10.84万
-
财政年份:1997
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
GENETIC CONTROL OF RESPONSIVENESS TO N20 ANTIOCICEPTION
-
批准号:2749123
-
项目类别:
-
资助金额:$2.09万
-
财政年份:1997
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
GENETIC CONTROL OF RESPONSIVENESS TO N20 ANTIOCICEPTION
-
批准号:2013429
-
项目类别:
-
资助金额:$13.71万
-
财政年份:1997
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
SIGNALING PATHWAY FOR BENZODIAZEPINE INDUCED BEHAVIORS
-
批准号:2634036
-
项目类别:
-
资助金额:$9.08万
-
财政年份:1997
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
GENETIC CONTROL OF RESPONSIVENESS TO N20 ANTIOCICEPTION
-
批准号:2897994
-
项目类别:
-
资助金额:$7.71万
-
财政年份:1997
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
SIGNALING PATHWAY FOR BENZODIAZEPINE INDUCED BEHAVIORS
-
批准号:2856550
-
项目类别:
-
资助金额:$9.03万
-
财政年份:1997
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
NITROUS OXIDE AND ENDORPHINS
-
批准号:3220395
-
项目类别:
-
资助金额:$6.05万
-
财政年份:1984
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
NITROUS OXIDE AND ENDOGENOUS OPIOID SYSTEMS
-
批准号:3220392
-
项目类别:
-
资助金额:$23.26万
-
财政年份:1984
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
NITROUS OXIDE AND ENDORPHINS
-
批准号:3220396
-
项目类别:
-
资助金额:$6.48万
-
财政年份:1984
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
NITROUS OXIDE AND ENDOGENOUS OPIOID SYSTEMS
-
批准号:2129410
-
项目类别:
-
资助金额:$19.28万
-
财政年份:1984
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
NITROUS OXIDE AND ENDOGENOUS OPIOID SYSTEMS
-
批准号:3220397
-
项目类别:
-
资助金额:$20.78万
-
财政年份:1984
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
NITROUS OXIDE AND ENDOGENOUS OPIOID SYSTEMS
-
批准号:3220394
-
项目类别:
-
资助金额:$0.21万
-
财政年份:1984
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
NITROUS OXIDE AND ENDORPHINS
-
批准号:3220387
-
项目类别:
-
资助金额:$6.07万
-
财政年份:1984
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
海外基金